Bovine Lactoferrin Versus Ferrous Sulphate In The Treatment Of Iron Deficiency Anemia During Pregnancy
Status:
Unknown status
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
130 pregnant women with Iron deficiency anemia, in the 2nd trimester (microcytic hypochromic
anemia, hemoglobin range from 9-10.5g/dl, serum ferritin less than 12 ng/ml), from the
outpatient clinics in the Obstetrics and Gynecology Department, in Ain Shams University
Hospital, Cairo, Egypt, will be enrolled and distributed into one of 2 groups by a computer
generated random number table. Each of the 2 groups will receive 2 medication for 2 months
with specific instruction to increase iron absorption. One group named L will receive powders
of bovine lactoferrin and tablets of placebo form, the 2nd named F will receive ferrous
sulphate tablet and placebo in powder form. Hemoglobin concentration, packed-cell volume
(PCV) , mean cell volume (MCV), mean corpuscular hemoglobin (MCH), mean cell hemoglobin
concentration (MCHC), Serum ferritin will be done at the start and the end of the treatment
period.